Capital Group Private Client Services, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Capital Group Private Client Services, Inc.
- $9.55 Billion
- Q1 2025
A detailed history of Capital Group Private Client Services, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 1,856 shares of ALNY stock, worth $571,648. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,856
Previous 41,525
95.53%
Holding current value
$571,648
Previous $9.77 Million
94.87%
% of portfolio
0.01%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding ALNY
# of Institutions
720Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.16 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.02 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.94 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.2 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.36 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $37.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...